SPOTLIGHT: Tossing and turning? Maybe it's the Zocor


Merck's cholesterol drug Zocor (simvastatin) may cause insomnia and other sleep disruptions, according to a new study that compared the remedy to its rival Pravachol, made by Bristol-Myers Squibb. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

A phase 1 study of the Inlyta-Keytruda regimen, which bears a first-line nod for kidney cancer, got the ax along with several Bavencio tests.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.